Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Q0HR
|
||||
Former ID |
DCL001041
|
||||
Drug Name |
Y-931
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Schizophrenia [ICD9: 295; ICD10:F20] | Terminated | [1] | ||
Company |
Mitsubishi Pharma
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C24H23FN4O4S
|
||||
Canonical SMILES |
C[NH+]1CC[N+](=C2C3=C(NC4=C(N2)C=CC(=C4)F)SC5=CC=CC=C53<br />)CC1.C(=CC(=O)[O-])C(=O)[O-]
|
||||
InChI |
1S/C20H19FN4S.C4H4O4/c1-24-8-10-25(11-9-24)19-18-14-4-2-3-5-17(14)26-20(18)23-16-12-13(21)6-7-15(16)22-19;5-3(6)1-2-4(7)8/h2-7,12H,8-11H2,1H3,(H,22,23);1-2H,(H,5,6)(H,7,8)/b;2-1-
|
||||
InChIKey |
RHPQQODEPSPFTF-BTJKTKAUSA-N
|
||||
CAS Number |
CAS 221058-55-5
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | D(2) dopamine receptor | Target Info | Binder | [1] | |
KEGG Pathway | Rap1 signaling pathway | ||||
cAMP signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Gap junction | |||||
Dopaminergic synapse | |||||
Parkinson's disease | |||||
Cocaine addiction | |||||
Alcoholism | |||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Dopamine receptor mediated signaling pathway | |||||
Nicotine pharmacodynamics pathway | |||||
Reactome | Dopamine receptors | ||||
G alpha (i) signalling events | |||||
WikiPathways | Hypothetical Network for Drug Addiction | ||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Genes and (Common) Pathways Underlying Drug Addiction | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
Nicotine Activity on Dopaminergic Neurons | |||||
References | |||||
REF 1 | The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. Epub 2007 Jul 31. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.